
|Videos|December 2, 2021
Dr. Kutikov on optimal use of blue light cystoscopy with Cysview
Author(s)Urology Times staff
"I think for the right patient, Cysview technology has a big deliverable,” says Alexander Kutikov, MD, FACS.
Advertisement
In this video, Alexander Kutikov, MD, FACS, discusses his own experience using Cysview and what he has found to be the most optimal conditions for using this technology. Kutikov is the chief of the division of urology and urologic oncology, professor in the department of surgical oncology, and the Roberta R. Scheller Chair in urologic oncology at the Fox Chase Cancer Center at Temple University in Philadelphia, Pennsylvania.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Dosing begins in trial of alpha radioligand therapy for mCRPC
2
Novel tool may help predict early PSA response to ARPIs in mHSPC
3
Fed Ghali, MD, highlights trial of consolidative local therapy following EV/P
4
RCMIGI trial supports feasibility of reduced margins in image-guided prostate radiotherapy
5




















